1,524
Participants
Start Date
May 4, 2022
Primary Completion Date
March 2, 2023
Study Completion Date
March 2, 2023
QIAstat-Dx® Meningitis/Encephalitis (ME) Panel
The performance of QIAstat-Dx® Meningitis/Encephalitis Panel will be evaluated in comparison with another validated comparator method, followed by bidirectional sequencing using residual specimens of cerebrospinal fluid (CSF) obtained by lumbar puncture from subjects with signs and symptoms of meningitis and/or encephalitis.
Qiagen, Manchester
QIAGEN Gaithersburg, Inc
INDUSTRY